Urotensin-II levels in acute coronary syndromes.

[1]  N. Aiyar,et al.  Production and characterization of monoclonal antibodies against the vasoconstrictive peptide human urotensin-II. , 2003, Hybridoma and hybridomics.

[2]  I. Toth,et al.  Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. , 2003, American journal of physiology. Heart and circulatory physiology.

[3]  S. Douglas.  Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'? , 2003, Current opinion in pharmacology.

[4]  I. Squire,et al.  Plasma Urotensin in Human Systolic Heart Failure , 2002, Circulation.

[5]  A. Richards,et al.  Plasma urotensin II in heart failure , 2002, The Lancet.

[6]  S. Douglas,et al.  Congestive heart failure and expression of myocardial urotensin II , 2002, The Lancet.

[7]  J. Pernow,et al.  Urotensin II evokes potent vasoconstriction in humans in vivo , 2002, British journal of pharmacology.

[8]  S. Ito,et al.  Role of urotensin II in patients on dialysis , 2001, The Lancet.

[9]  T. Sauerbruch,et al.  Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension. , 2001, Journal of hepatology.

[10]  S. Douglas,et al.  Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries. , 2001, American journal of physiology. Heart and circulatory physiology.

[11]  P. Molenaar,et al.  Cardiostimulant effects of urotensin‐II in human heart in vitro , 2001, British journal of pharmacology.

[12]  A. Davenport,et al.  Orphan‐receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin‐1 , 2000, British journal of pharmacology.

[13]  H. Sarau,et al.  Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 , 1999, Nature.

[14]  T. Lüscher,et al.  Endothelin-1-induced release of thromboxane A2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts. , 1996, Circulation.

[15]  D. Webb,et al.  Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome. , 1994, British heart journal.

[16]  R. T. Lie,et al.  Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. , 1994, Circulation.

[17]  L. Opie,et al.  Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts. , 1992, Journal of molecular and cellular cardiology.

[18]  S. Ito,et al.  Increased plasma urotensin II levels in patients with diabetes mellitus. , 2003, Clinical science.